Michelson Diagnostics

Aug 24, 2023

Michelson Diagnostics Limited Strategic Development On 25 July 2022, STRATA Skin Sciences, Inc., a healthcare technology company focused on developing, commercializing, and branding innovative products for the treatment of dermatologic conditions, announced the commercial launch in the United States of TheraClearX, a non-invasive, in-office acne treatment that targets the underlying causes of mild to moderate acne, such as comedonal, pustular as well as inflammatory acne vulgaris. On 1 June 2022, Cynosure introduced the PicoSure Pro gadget, the newest addition to the PicoSure system. The PicoSure Pro device, an FDA-cleared 755nm picosecond laser, produces energy in a trillionth of a second, employing pressure rather than heat to offer safe as well as efficient solutions for undesired pigmentation and skin renewal for all skin types. You can conveniently place your order directly through this provided link @  https://www.emergenresearch.com/select-license/1462 Some Key Highlights From the Report The treatment devices segment is expected to account for the largest revenue share during the forecast period which is attributed to the accessibility of a wide range of dermatological treatment options and introduction of innovative laser device technologies. For example, Lumenis Ltd., the world's leading producer of energy-based medical devices for cosmetic, surgical, and ophthalmic applications, launched the NuEra Tight with FocalRF technology on 17 August 2020. The technology provides a breakthrough in personalized non-invasive RF body treatments that are tailored to each patient's exact demands, helping to drive market revenue growth. The diagnostic devices segment is expected to register a steady CAGR during the forecast period. It is further sub-segmented into skin cancer diagnosis and others. Given the rise in skin cancer prevalence, the sub-segment of skin cancer diagnosis has the largest revenue share. Furthermore, new research and development on skin cancer diagnostics is driving market revenue growth. For example, roughly 3.3 million individuals in the United States are diagnosed with basal and squamous cell carcinomas each year. URSKIN is a device created by researchers at Huntsman Cancer Institute (HCI) and the University of Utah that employs a technology known as non-visual electrical impedance demography to exploit changes in the electrical properties of skin that occur during cancer cell proliferation (EID). Market in North America is expected to account for the largest revenue share during the forecast period, which is attributed primarily to rising frequency of skin cancer and other skin conditions such as atopic dermatitis and psoriasis, as well as widespread awareness of cosmetic operations. Acne, for example, is the most common skin condition in the United States, affecting up to 50 million individuals each year. Acne affects around 85 percent of individuals between the ages of 12 and 24. According to recent studies, about 8 million individuals in the United States suffer from psoriasis. As a result, the region's expanding prevalence of skin disorders is rising demand for dermatological devices. Feel free to explore the complete report description, research methodology, table of contents, and accompanying infographics by following this link @ https://www.emergenresearch.com/industry-report/dermatology-devices-market Emergen Research has segmented the global dermatology devices market on the basis of product, application, end-use, and region: Product Outlook (Revenue, USD Billion; 2019–2030) Diagnostic Devices Diagnostic Devices Hospitals North America Curated Reports You Shouldn't Miss: Dive In Now! Electrosurgical Devices Market By Method (Bipolar, Monopolar), By Product (Active electrodes, Electrosurgical Generators, Electrosurgical Instruments and Accessories), By Surgery Type (General surgery, Cosmetic, Cardiovascular), Forecasts to 2027 Interventional Cardiology Market By Product (Catheters, Angioplasty Balloons, Plaque Modification Devices, Angioplasty Stents), By End Users (Cardiac Catheterization labs, Hospitals, Ambulatory surgical centers), Forecasts to 2027 Injectable Drug Delivery Market , By Device Type (Conventional Injectables, Pre-Filled Syringes, Auto-Injectors, Pen-Injectors), By Product Type (Freeze-Dried Products, Injectable Sterile Products), By End-use, and By Region Forecast to 2030 Molecular Diagnostics Market , By Product & Services (Reagent, Instrument, Software & Service), By Technology (Polymerase Chain Reaction), By Application, By End-Use, By Test Location, and By Region Forecast to 2030 Teleradiology Services Market By Imaging Technique (MRI, CT, X-Rays, Ultrasound, Mammography), By End-Users (Diagnostic Centers, Hospitals & Clinics), By Products and Services (Software, Hardware, Teleradiology services), Forecasts to 2027 Biomaterials Market By Type (Ceramic, Metallic, Polymeric, Natural, Others), By Application (Cardiovascular, Ophthalmology, Orthopedic, Plastic Surgery, Neurology, Others), and Regions Forecasts to 2027 Phototherapy Devices Market By Product (LED, Fibreoptic, Conventional Phototherapy Devices), By Application (Neonatal Jaundice Management, Skin Disease Treatment), By End User (Homecare, Hospitals & Clinics), Forecasts to 2027 About Emergen Research Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. Contact Us: